Market Cap 170.63M
Revenue (ttm) 1.07B
Net Income (ttm) 99.41M
EPS (ttm) N/A
PE Ratio 5.05
Forward PE 30.10
Profit Margin 9.27%
Debt to Equity Ratio 0.00
Volume 200,600
Avg Vol 236,348
Day's Range N/A - N/A
Shares Out 10.94M
Stochastic %K 7%
Beta 1.15
Analysts Hold
Price Target $16.50

Latest News on MED

Medifast, Inc. (MED) Q3 2024 Earnings Call Transcript

Nov 4, 2024, 5:56 PM EST - 2 months ago

Medifast, Inc. (MED) Q3 2024 Earnings Call Transcript


Medifast Announces Third Quarter 2024 Financial Results

Nov 4, 2024, 4:05 PM EST - 2 months ago

Medifast Announces Third Quarter 2024 Financial Results